Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry-Reference-Cited by-同舟云学术

Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry

Published:2020-08-01 Issue:4 Volume:84 Page:e24-e28
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Canetti Diana,Galli Laura,Gianotti Nicola,Celotti Anna,Calza Leonardo,Gagliardini Roberta,Rusconi Stefano,Modica Sara,Cenderello Giovanni,Ferrara Micol,Santoro Maria Mercedes,Zazzi Maurizio,Castagna Antonella,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference6 articles.

1. New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations;Davy-Mendez;AIDS.,2018

2. Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity;Tashima;HIV Clin Trials.,2015

3. Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new score;De Luca;Antivir Ther.,2011

4. Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment;Armenia;J Clin Virol.,2018

5. The dawn of precision medicine in HIV: state of the art of pharmacotherapy;Mu;Expert Opin Pharmacother.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO Registry;International Journal of Antimicrobial Agents;2024-07

2. Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors;BMJ Open;2024-02

3. Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study;Journal of Global Antimicrobial Resistance;2022-12

4. Achieving virological control in pan-resistant HIV-1 infection: A case series;eBioMedicine;2022-03